| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1019 |
Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) |
541,958 |
33,859 |
$39.00M |
| S5125 |
Attendant care services; per 15 minutes |
648,697 |
29,197 |
$38.25M |
| T2016 |
Habilitation, residential, waiver; per diem |
153,178 |
7,507 |
$22.95M |
| T1005 |
Respite care services, up to 15 minutes |
139,485 |
10,407 |
$12.17M |
| T2040 |
Financial management, self-directed, waiver; per 15 minutes |
79,478 |
76,315 |
$11.42M |
| T2017 |
Habilitation, residential, waiver; 15 minutes |
88,289 |
3,997 |
$7.75M |
| H2015 |
Comprehensive community support services, per 15 minutes |
80,776 |
5,062 |
$6.94M |
| M0355 |
|
27,878 |
1,095 |
$4.46M |
| G0749 |
|
31,831 |
3,940 |
$3.55M |
| S9125 |
Respite care, in the home, per diem |
27,495 |
3,685 |
$2.08M |
| M0361 |
|
13,922 |
832 |
$2.04M |
| M0373 |
|
24,096 |
2,177 |
$919K |
| M0111 |
|
3,393 |
3,392 |
$659K |
| G0227 |
|
4,380 |
4,375 |
$490K |
| M0241 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses |
4,369 |
585 |
$477K |
| M0209 |
|
2,466 |
2,465 |
$474K |
| G0226 |
|
2,235 |
2,235 |
$461K |
| G6063 |
|
11,766 |
3,256 |
$223K |
| M0145 |
|
2,054 |
431 |
$177K |
| M0539 |
|
4,669 |
1,324 |
$43K |
| M0420 |
|
873 |
199 |
$43K |
| G6064 |
|
719 |
664 |
$38K |
| M0538 |
|
294 |
271 |
$6K |